A Single-Dose Crossover Oral Bioequivalence Study of PL 3100 and Naproxen in Healthy Adult Volunteers in the Fasted State.

Trial Profile

A Single-Dose Crossover Oral Bioequivalence Study of PL 3100 and Naproxen in Healthy Adult Volunteers in the Fasted State.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 10 Sep 2015

At a glance

  • Drugs Naproxen (Primary)
  • Indications Pain
  • Focus Pharmacokinetics
  • Sponsors PLx Pharma
  • Most Recent Events

    • 13 May 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
    • 13 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top